Xie Qin, Ding Jian, Chen Yi
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310012, China.
Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Acta Pharm Sin B. 2021 Jun;11(6):1365-1378. doi: 10.1016/j.apsb.2021.03.027. Epub 2021 Apr 24.
CD8 T lymphocytes are pivotal cells in the host response to antitumor immunity. Tumor-driven microenvironments provide the conditions necessary for regulating infiltrating CD8 T cells in favor of tumor survival, including weakening CD8 T cell activation, driving tumor cells to impair immune attack, and recruiting other cells to reprogram the immune milieu. Also in tumor microenvironment, stromal cells exert immunosuppressive skills to avoid CD8 T cell cytotoxicity. In this review, we explore the universal function and fate decision of infiltrated CD8 T cells and highlight their antitumor response within various stromal architectures in the process of confronting neoantigen-specific tumor cells. Thus, this review provides a foundation for the development of antitumor therapy based on CD8 T lymphocyte manipulation.
CD8 T淋巴细胞是宿主抗肿瘤免疫反应中的关键细胞。肿瘤驱动的微环境提供了调节浸润性CD8 T细胞以利于肿瘤存活的必要条件,包括削弱CD8 T细胞活化、促使肿瘤细胞损害免疫攻击,以及招募其他细胞来重新编程免疫微环境。同样在肿瘤微环境中,基质细胞发挥免疫抑制作用以避免CD8 T细胞的细胞毒性。在本综述中,我们探讨了浸润性CD8 T细胞的普遍功能和命运决定,并强调了它们在面对新抗原特异性肿瘤细胞过程中,在各种基质结构内的抗肿瘤反应。因此,本综述为基于CD8 T淋巴细胞操控的抗肿瘤治疗发展提供了基础。